Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Outsourcing-pharma
32m
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
41m
Novo Nordisk CEO warns of deaths linked to compounded semaglutide
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump wins reelection
Delivers concession speech
Alleged forged ballot arrests
Song identified after 17 yrs
Girl wins $300K settlement
Winter storm warning
Court orders new trial
Navy fires ethics leader
Clinches 20th House term
Biden congratulates Trump
Arctic oil refuge plan
Weekly jobless claims rise
Nearly 1 in 6 adults diabetic
Jackson mayor indicted
Israel signs F-15 deal
Plot to join ISIS arrest
Drivers win union rights
Nissan to cut 9,000 jobs
Wildfire forces evacuations
Facebook shareholder suit
Bitcoin hits all-time high
News anchor dies at 39
3 states pass leave laws
To succeed late Jackson Lee
Lebanon files UN complaint
Flips Michigan House seat
Elected LA County DA
Bresnahan ousts Cartwright
Related topics
Novo Nordisk
Ozempic
United States
Food and Drug Administration
MASH
Feedback